Medicines Being Studied
1) NMSOAP’s inaugural study is collecting information from patients who are taking orally-administered “blood thinner” medications for the prevention of atrial fibrillation-related stroke or venous thromboembolic (VTE) disease-related pulmonary embolus (blood clots to the lungs). The following are qualifying medications:
- Coumadin® (warfarin)
- Eliquis® (apixaban)
- Pradaxa® (dabigatran)
- Xarelto® (rivaroxaban)